Addressing patient heterogeneity in disease predictive model development.

Area of Science:

• Biomedical data analysis
• Statistical modeling
• Biostatistics

Background:

• Patient heterogeneity complicates accurate predictions in biomedical applications.
• Identifying distinct patient subgroups is crucial for personalized medicine and effective treatment strategies.
• Existing methods may not adequately capture complex subgroup structures in patient data.

Purpose of the Study:

• To develop a systematic hypothesis testing framework for detecting patient subgroup structures.
• To determine the optimal number of subgroups within a patient population.
• To model the relationship between disease outcomes, patient characteristics, and clinical factors using mixture models.

Main Methods:

• Utilizing a mixture of generalized linear models to represent disease outcome relationships.
• Constructing a test statistic based on the expectation-maximization (EM) algorithm.
• Deriving the asymptotic distribution of the test statistic under the null hypothesis.
• Employing a computational approach requiring minimal EM iterations for parameter estimation.

Main Results:

• The proposed hypothesis test effectively identifies patient subgroup structures.
• Simulation studies confirm the test's robust performance regarding type-I error rates and statistical power.
• The method demonstrated practical applicability in a multicenter prostate cancer study.

Conclusions:

• The developed hypothesis testing approach provides a robust tool for identifying patient heterogeneity.
• This method enhances the accuracy of prediction models in biomedical applications by accounting for subgroups.
• The approach offers a computationally efficient way to analyze complex patient data for clinical insights.